Literature DB >> 25087692

Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.

Peter De Cruz1, Seungha Kang, Josef Wagner, Michael Buckley, Winnie H Sim, Lani Prideaux, Trevor Lockett, Chris McSweeney, Mark Morrison, Carl D Kirkwood, Michael A Kamm.   

Abstract

BACKGROUND AND AIM: Crohn's disease pathogenesis involves alterations in the gut microbiota. We characterized the mucosa-associated microbiota at the time of surgical resection and 6 months later to identify bacterial profiles associated with recurrence and remission.
METHODS: Tissue samples were collected from surgical resection specimens in 12 Crohn's disease patients, and at 6 months postoperative colonoscopy from the neoterminal ileum and anastomosis. Endoscopic recurrence was assessed using the Rutgeerts score. Microbiota was characterized using microarray and 454 pyrosequencing. Longitudinal comparisons were made within patients, and cross-sectional comparisons made with colonoscopic biopsies from the terminal ileum and cecum of 10 healthy subjects.
RESULTS: Microbiota of healthy subjects had high diversity and was dominated by the Firmicutes, Bacteroidetes, and Proteobacteria phyla. Biodiversity was lower in Crohn's disease patients at the time of surgery, increased after surgery, but still differed from healthy subjects. Crohn's disease patients with recurrent disease retained a microbiota favoring proteolytic-fueled fermentation and lactic acid-producing bacteria, including Enterococcus and Veillonella spp., while those maintaining remission demonstrated predominant saccharolytic Bacteroides, Prevotella, and Parabacteroides spp., and saccharolytic, butyrate-producing Firmicutes.
CONCLUSION: In Crohn's disease, the mucosa-associated microbiota diversity is reduced at the time of surgery, but also differs between patients with different clinical outcomes at 6 months. These findings may provide prognostic information at the time of surgery, allowing identification of patients at increased risk of recurrence, and provide basis for a more targeted approach for therapeutic interventions after surgery.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Crohn's disease; enteric bacterial flora; inflammatory bowel disease; metagenomic

Mesh:

Substances:

Year:  2015        PMID: 25087692     DOI: 10.1111/jgh.12694

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  60 in total

1.  Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.

Authors:  K P Economopoulos; N L Ward; C D Phillips; A Teshager; P Patel; M M Mohamed; S Hakimian; S B Cox; R Ahmed; O Moaven; K Kaliannan; S N Alam; J F Haller; A M Goldstein; A K Bhan; M S Malo; R A Hodin
Journal:  Diabetes Obes Metab       Date:  2016-03-22       Impact factor: 6.577

Review 2.  Gastrointestinal surgery and the gut microbiome: a systematic literature review.

Authors:  Suzie Ferrie; Amy Webster; Betty Wu; Charis Tan; Sharon Carey
Journal:  Eur J Clin Nutr       Date:  2020-07-13       Impact factor: 4.016

3.  Prebiotic Supplementation Following Ileocecal Resection in a Murine Model is Associated With a Loss of Microbial Diversity and Increased Inflammation.

Authors:  Michael Laffin; Troy Perry; Heekuk Park; Naomi Hotte; Richard N Fedorak; Aducio Thiesen; Bryan Dicken; Karen L Madsen
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

Review 4.  Update on the Gastrointestinal Microbiome in Systemic Sclerosis.

Authors:  Chiara Bellocchi; Elizabeth R Volkmann
Journal:  Curr Rheumatol Rep       Date:  2018-06-25       Impact factor: 4.592

Review 5.  The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Authors:  Samantha N Freedman; Shailesh K Shahi; Ashutosh K Mangalam
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

6.  Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome.

Authors:  Paola Menghini; Daniele Corridoni; Ludovica F Buttó; Abdullah Osme; Sushma Shivaswamy; Minh Lam; Giorgos Bamias; Theresa T Pizarro; Alexander Rodriguez-Palacios; Charles A Dinarello; Fabio Cominelli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 7.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 8.  Probiotics, Nutrition, and the Small Intestine.

Authors:  Taylor C Judkins; Douglas L Archer; Dean C Kramer; Rebecca J Solch
Journal:  Curr Gastroenterol Rep       Date:  2020-01-13

9.  Luminal microbiota related to Crohn's disease recurrence after surgery.

Authors:  Amy L Hamilton; Michael A Kamm; Peter De Cruz; Emily K Wright; Hai Feng; Josef Wagner; Joseph J Y Sung; Carl D Kirkwood; Michael Inouye; Shu-Mei Teo
Journal:  Gut Microbes       Date:  2020-06-21

10.  Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites.

Authors:  Alison N Thorburn; Craig I McKenzie; Sj Shen; Dragana Stanley; Laurence Macia; Linda J Mason; Laura K Roberts; Connie H Y Wong; Raymond Shim; Remy Robert; Nina Chevalier; Jian K Tan; Eliana Mariño; Rob J Moore; Lee Wong; Malcolm J McConville; Dedreia L Tull; Lisa G Wood; Vanessa E Murphy; Joerg Mattes; Peter G Gibson; Charles R Mackay
Journal:  Nat Commun       Date:  2015-06-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.